| Stage | CVNA | % of rev | RUSHA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $1.9B | 100.00% | CVNA ×4.23 |
| Gross profit | $1.5B | 18.92% | $362M | 19.04% | RUSHA +0.1pp |
| Operating income | $714M | 8.88% | $97M | 5.12% | CVNA +3.8pp |
| Pre-tax income | $552M | 6.87% | $92M | 4.86% | CVNA +2.0pp |
| Net income | $483M | 6.01% | $73M | 3.84% | CVNA +2.2pp |
| Stage | CVNA | RUSHA | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $1.9B100.00% | CVNA ×4.23 |
| Gross profit | 18.92%$1.5B | 19.04%$362M | RUSHA +0.1pp |
| Operating income | 8.88%$714M | 5.12%$97M | CVNA +3.8pp |
| Pre-tax income | 6.87%$552M | 4.86%$92M | CVNA +2.0pp |
| Net income |
| 6.01%$483M |
| 3.84%$73M |
| CVNA +2.2pp |
No shared counterparties.